FIRST 5-YEARS RESULTS OF ROUTINE INTRACAVITARY ADMINISTRATION OF COLLOIDAL RADIOACTIVE GOLD (Au$sup 198$) FOR THE TREATMENT OF OVARIAN CANCER
Technical Report
·
OSTI ID:4272947
A report is presented on the first 5-years results of routine intraperitoneal and intrapleural administration of colloidal radioactive gold (Au/ sup 198/) for the treatment of ovarian cancer in an unselected group of 51 patients. These results indicate that such isotope, administration is a true progress in the field of cancer therapy, since it does at least double the salvage rate of the ovarian cancer patients with surgically resectable primaries. (auth)
- Research Organization:
- Univ. of Zurich
- NSA Number:
- NSA-13-006090
- OSTI ID:
- 4272947
- Report Number(s):
- A/CONF.15/P/234
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Similar Records
Integration of new therapies and radiation in the management of ovarian cancer
COMPARATIVE STUDIES OF THE DISTRIBUTION OF RADIOACTIVE COLLOID GOLD Au$sup 198$ AND RADIOACTIVE COLLOID GOLD COVERED WITH SILVER IN INTRA-ABDOMINAL ADMINISTRATION
Intracavitary chromic phosphate (32P) colloidal suspension therapy
Journal Article
·
Wed Jul 15 00:00:00 EDT 1981
· Cancer (Philadelphia); (United States)
·
OSTI ID:5449822
COMPARATIVE STUDIES OF THE DISTRIBUTION OF RADIOACTIVE COLLOID GOLD Au$sup 198$ AND RADIOACTIVE COLLOID GOLD COVERED WITH SILVER IN INTRA-ABDOMINAL ADMINISTRATION
Journal Article
·
Fri Jun 01 00:00:00 EDT 1962
· Meditsinskaya Radiologiya (U.S.S.R.) For English translation see Med. Radiol., USSR
·
OSTI ID:4809017
Intracavitary chromic phosphate (32P) colloidal suspension therapy
Journal Article
·
Mon Dec 14 23:00:00 EST 1981
· Cancer (Philadelphia); (United States)
·
OSTI ID:5462791